PD
Paul Da Silva Jardine
Venture Partner at Apple Tree Partners
Guilford, Connecticut
Overview
Paul Da Silva Jardine is a Venture Partner at Apple Tree Partners, with a background in the pharmaceutical industry and expertise in areas such as biotechnology, clinical trials, and drug development. He has held key roles at Staten Biotechnology and Pfizer, where he served as Chief Scientific Officer and Vice President in various research and development capacities.
Jardine's career highlights include leading research teams at Pfizer in cardiovascular and metabolic diseases, as well as making strategic investments in companies like Red Queen Therapeutics, Deep Apple Therapeutics, and Aethon Therapeutics at Apple Tree Partners.
Work Experience
Venture Partner
2021 - Current
Chief Scientific Officer
2015
Staten Biotechnology is a Precision Medicine Cardiovascular and Dyslipidemic company for targets with robust human genetics support
Vice President Cardiovascular and Metabolic Research
2009 - 2015
Vice President, Head of Cardiovascular and Metabolic and Endocrine Diseases Chemistry
2004 - 2009
Senior Director, Head of Obesity and Osteoporosis Chemistry CVMED
2001 - 2004
Research Scientist to Director Chemistry
1989 - 2001
Pfizer is a biopharmaceutical company that provides affordable access to safe, effective medicines and health care services.
Raised $32,000,000,000.00 from Starboard Value.